Summary Information:
Arbutus Biopharma Corporation Common Stock
NASDAQ:ABUS


email
[email protected]
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Arbutus Biopharma Corporation Common Stock
Exchange: NASDAQ
Symbol: ABUS
SEC CIK: 0001447028
Phone: 604-419-3200
100-8900 GLENLYON PARKWAY
BURNABY A1 V5J 5J8

CEO: William Collier
Price when page updated: 1.905 Date: 2023-11-30
Company Website:
arbutusbio.com

_Description: Arbutus Biopharma Corporation is a biopharmaceutical company primarily dedicated to discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection. The Company is advancing multiple drug product candidates that may be combined into a potentially curative regimen for chronic HBV infection. Arbutus has also initiated a drug discovery and development effort for treating coronaviruses (including COVID-19).

IPO YEAR:

Sector:

Industry:

ADRTSO:

MarketCap:
319459446.00
Beta:
0.501187886264094
52 Week High:
6.5
52 Week Low:
2.43
52 Week Change:
0.07493540051679592
Short Interest:

Short Date:

Shares Outstanding:
135269247
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
3 Nov 2022
Float:
0
return on Equity:
-66.50%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
-$63.71
ttmEPS:
-0.9166
Revenue:
$33.368M
Gross Profit:

Cash:

Debt:

Institution Percent:
29.90%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
26.89%
Return on Assets:
-37.00%
Return on Capital:

Profit Margin:
-
Price to Sales:
10.28
Price To Book:
2.19
Short Ratio:
5.01
PE Ratio:
-6.493723083456426
Employees:
77
1Y Guesstimate
5.089:2.0:6




__The following are links to various summary and news pages for
__Arbutus Biopharma Corporation Common Stock [ ABUS ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30